Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)

S. R. Verhoeff, S. Es, E. Boon, E. van Helden, L. Angus, S. Elias, S. Oosting, E. Aarntzen, A. Brouwers, S. Heskamp, O. S. Hoekstra, H. M. Verheul, A. A.M. Van der Veldt, E. G.E. de Vries, O. Boerman, W. T.A. van der Graaf, W. J.G. Oyen, C. M.L. van Herpen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)viii314-viii315
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Publication statusPublished - 1 Oct 2018

Cite this